A groundbreaking FDA approval has introduced a new treatment option specifically designed for colorectal cancer patients with ...

Working with a line of colon cancer cells, Korean researchers figured out a way to throw a few genetic switches to cause the ...

Korean researchers have developed a technology that treats colon cancer by converting cancer cells into a state resembling ...

KAIST researchers have developed new technology that can transform colon cancer cells into normal-like cells. Led by ...

Cancer is a deadly disease taking the lives of thousands of people worldwide, and researchers are constantly looking for ...

Amivantamab is under clinical development by Johnson & Johnson and currently in Phase III for Metastatic Colorectal Cancer.

3. In July, the FDA approved a new screening test for CRC that only requires a sample of blood. The test, created by Palo Alto, Calif.-based Guardant Health, was able to detect 83% of colorectal ...

T he US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to a cancer drug called dostarlimab ...

Jimmy Carter’s 2015 melanoma diagnosis introduced the world to immunotherapy, sparking future cancer research. Millions of ...

Scientists at KAIST have developed a groundbreaking method to convert colon cancer ... preventing cancer recurrence and minimizing side effects associated with traditional treatments like ...

The most-read articles focused on the new colonoscopy guidelines, the relationship between diabetes and colorectal cancer, ...

A new innovative treatment has been developed that can cause cancerous cells to revert to their original healthy state.In the ...